These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 27511006)
21. A toxic mutant huntingtin species is resistant to selective autophagy. Fu Y; Wu P; Pan Y; Sun X; Yang H; Difiglia M; Lu B Nat Chem Biol; 2017 Nov; 13(11):1152-1154. PubMed ID: 28869595 [TBL] [Abstract][Full Text] [Related]
22. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease. Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486 [TBL] [Abstract][Full Text] [Related]
23. MnFe Zhang L; Wei PF; Song YH; Dong L; Wu YD; Hao ZY; Fan S; Tai S; Meng JL; Lu Y; Xue J; Liang CZ; Wen LP Biomaterials; 2019 Sep; 216():119248. PubMed ID: 31226569 [TBL] [Abstract][Full Text] [Related]
24. Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes. Chou SY; Weng JY; Lai HL; Liao F; Sun SH; Tu PH; Dickson DW; Chern Y J Neurosci; 2008 Mar; 28(13):3277-90. PubMed ID: 18367595 [TBL] [Abstract][Full Text] [Related]
25. Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex. Li XJ; Zhang YY; Fu YH; Zhang H; Li HX; Li QF; Li HL; Tan RK; Jiang CX; Jiang W; Li ZX; Luo C; Lu BX; Dang YJ Acta Pharmacol Sin; 2021 Oct; 42(10):1556-1566. PubMed ID: 33495516 [TBL] [Abstract][Full Text] [Related]
26. GLP-1 Analogue Liraglutide Attenuates Mutant Huntingtin-Induced Neurotoxicity by Restoration of Neuronal Insulin Signaling. Chang CC; Lin TC; Ho HL; Kuo CY; Li HH; Korolenko TA; Chen WJ; Lai TJ; Ho YJ; Lin CL Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149534 [TBL] [Abstract][Full Text] [Related]
27. TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington's disease. Qin Y; Chen L; Zhu W; Song J; Lin J; Li Y; Zhang J; Song X; Xing T; Guo T; Duan X; Zhang Y; Ruan E; Wang Q; Li B; Yang W; Yin P; Yan XX; Li S; Li XJ; Yang S Sci Adv; 2024 May; 10(20):eadl2036. PubMed ID: 38758800 [TBL] [Abstract][Full Text] [Related]
28. Targeting the proteostasis network in Huntington's disease. Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease. Rippin I; Bonder K; Joseph S; Sarsor A; Vaks L; Eldar-Finkelman H Neurobiol Dis; 2021 Jul; 154():105336. PubMed ID: 33753290 [TBL] [Abstract][Full Text] [Related]
31. Dynamic recruitment of ubiquitin to mutant huntingtin inclusion bodies. Juenemann K; Jansen AHP; van Riel L; Merkx R; Mulder MPC; An H; Statsyuk A; Kirstein J; Ovaa H; Reits EA Sci Rep; 2018 Jan; 8(1):1405. PubMed ID: 29362455 [TBL] [Abstract][Full Text] [Related]
32. Soluble N-terminal fragment of mutant Huntingtin protein impairs mitochondrial axonal transport in cultured hippocampal neurons. Tian J; Yan YP; Zhou R; Lou HF; Rong Y; Zhang BR Neurosci Bull; 2014 Feb; 30(1):74-80. PubMed ID: 24362588 [TBL] [Abstract][Full Text] [Related]
33. Peripheral sequestration of huntingtin delays neuronal death and depends on N-terminal ubiquitination. Boulos A; Maroun D; Ciechanover A; Ziv NE Commun Biol; 2024 Aug; 7(1):1014. PubMed ID: 39155290 [TBL] [Abstract][Full Text] [Related]
34. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease. Caron NS; Banos R; Yanick C; Aly AE; Byrne LM; Smith ED; Xie Y; Smith SEP; Potluri N; Findlay Black H; Casal L; Ko S; Cheung D; Kim H; Seong IS; Wild EJ; Song JJ; Hayden MR; Southwell AL J Neurosci; 2021 Jan; 41(4):780-796. PubMed ID: 33310753 [TBL] [Abstract][Full Text] [Related]
35. Polyglutamine tracts regulate beclin 1-dependent autophagy. Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460 [TBL] [Abstract][Full Text] [Related]
36. NAADP-Evoked Ca Pereira CAS; Medaglia NC; Ureshino RP; Bincoletto C; Antonioli M; Fimia GM; Piacentini M; Pereira GJDS; Erustes AG; Smaili SS Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982672 [TBL] [Abstract][Full Text] [Related]
37. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific. Jansen AH; van Hal M; Op den Kelder IC; Meier RT; de Ruiter AA; Schut MH; Smith DL; Grit C; Brouwer N; Kamphuis W; Boddeke HW; den Dunnen WF; van Roon WM; Bates GP; Hol EM; Reits EA Glia; 2017 Jan; 65(1):50-61. PubMed ID: 27615381 [TBL] [Abstract][Full Text] [Related]
38. Impairment of the Glial Phagolysosomal System Drives Prion-Like Propagation in a Davis GH; Zaya A; Pearce MMP J Neurosci; 2024 May; 44(20):. PubMed ID: 38589228 [TBL] [Abstract][Full Text] [Related]
39. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein. Aladdin A; Király R; Boto P; Regdon Z; Tar K Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806 [TBL] [Abstract][Full Text] [Related]
40. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Faideau M; Kim J; Cormier K; Gilmore R; Welch M; Auregan G; Dufour N; Guillermier M; Brouillet E; Hantraye P; Déglon N; Ferrante RJ; Bonvento G Hum Mol Genet; 2010 Aug; 19(15):3053-67. PubMed ID: 20494921 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]